Literature DB >> 27281113

A Novel Imaging System Distinguishes Neoplastic from Normal Tissue During Resection of Soft Tissue Sarcomas and Mast Cell Tumors in Dogs.

Suzanne Bartholf DeWitt1, William C Eward1, Cindy A Eward2, Alexander L Lazarides1, Melodi Javid Whitley1, Jorge M Ferrer3, Brian E Brigman1, David G Kirsch1, John Berg4.   

Abstract

OBJECTIVE: To assess the ability of a novel imaging system designed for intraoperative detection of residual cancer in tumor beds to distinguish neoplastic from normal tissue in dogs undergoing resection of soft tissue sarcoma (STS) and mast cell tumor (MCT). STUDY
DESIGN: Non-randomized prospective clinical trial. ANIMALS: 12 dogs with STS and 7 dogs with MCT.
METHODS: A fluorescent imaging agent that is activated by proteases in vivo was administered to the dogs 4-6 or 24-26 hours before tumor resection. During surgery, a handheld imaging device was used to measure fluorescence intensity within the cancerous portion of the resected specimen and determine an intensity threshold for subsequent identification of cancer. Selected areas within the resected specimen and tumor bed were then imaged, and biopsies (n=101) were obtained from areas that did or did not have a fluorescence intensity exceeding the threshold. Results of intraoperative fluorescence and histology were compared.
RESULTS: The imaging system correctly distinguished cancer from normal tissue in 93/101 biopsies (92%). Using histology as the reference, the sensitivity and specificity of the imaging system for identification of cancer in biopsies were 92% and 92%, respectively. There were 10/19 (53%) dogs which exhibited transient facial erythema soon after injection of the imaging agent which responded to but was not consistently prevented by intravenous diphenhydramine.
CONCLUSION: A fluorescence-based imaging system designed for intraoperative use can distinguish canine soft tissue sarcoma (STS) and mast cell tumor (MCT) tissue from normal tissue with a high degree of accuracy. The system has potential to assist surgeons in assessing the adequacy of tumor resections during surgery, potentially reducing the risk of local tumor recurrence. Although responsive to antihistamines, the risk of hypersensitivity needs to be considered in light of the potential benefits of this imaging system in dogs. © Copyright 2016 by The American College of Veterinary Surgeons.

Entities:  

Mesh:

Year:  2016        PMID: 27281113      PMCID: PMC4970890          DOI: 10.1111/vsu.12487

Source DB:  PubMed          Journal:  Vet Surg        ISSN: 0161-3499            Impact factor:   1.495


  22 in total

1.  Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.

Authors:  T P Olson; J Harter; A Muñoz; D M Mahvi; Tm Breslin
Journal:  Ann Surg Oncol       Date:  2007-08-03       Impact factor: 5.344

2.  A spatially and temporally restricted mouse model of soft tissue sarcoma.

Authors:  David G Kirsch; Daniela M Dinulescu; John B Miller; Jan Grimm; Philip M Santiago; Nathan P Young; G Petur Nielsen; Bradley J Quade; Christopher J Chaber; Christian P Schultz; Osamu Takeuchi; Roderick T Bronson; Denise Crowley; Stanley J Korsmeyer; Sam S Yoon; Francis J Hornicek; Ralph Weissleder; Tyler Jacks
Journal:  Nat Med       Date:  2007-08-05       Impact factor: 53.440

3.  Detection limits of intraoperative near infrared imaging for tumor resection.

Authors:  Greg M Thurber; Jose-Luiz Figueiredo; Ralph Weissleder
Journal:  J Surg Oncol       Date:  2010-12-01       Impact factor: 3.454

4.  Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision.

Authors:  Chick Weisse; Frances S Shofer; Karin Sorenmo
Journal:  J Am Anim Hosp Assoc       Date:  2002 Jan-Feb       Impact factor: 1.023

Review 5.  Prognostic factors for cutaneous and subcutaneous soft tissue sarcomas in dogs.

Authors:  M M Dennis; K D McSporran; N J Bacon; F Y Schulman; R A Foster; B E Powers
Journal:  Vet Pathol       Date:  2010-12-07       Impact factor: 2.221

6.  Recurrence rate, clinical outcome, and cellular proliferation indices as prognostic indicators after incomplete surgical excision of cutaneous grade II mast cell tumors: 28 dogs (1994-2002).

Authors:  Bernard Séguin; M Faulkner Besancon; Jennifer L McCallan; Loralei L Dewe; Matthew C Tenwolde; Emily K Wong; Michael S Kent
Journal:  J Vet Intern Med       Date:  2006 Jul-Aug       Impact factor: 3.333

7.  Marginal excision of low-grade spindle cell sarcoma of canine extremities: 35 dogs (1996-2006).

Authors:  Damiano Stefanello; Emanuela Morello; Paola Roccabianca; Selina Iussich; Claudia Nassuato; Marina Martano; Chiara Squassino; Giancarlo Avallone; Stefano Romussi; Paolo Buracco
Journal:  Vet Surg       Date:  2008-07       Impact factor: 1.495

8.  Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996).

Authors:  C A Kuntz; W S Dernell; B E Powers; C Devitt; R C Straw; S J Withrow
Journal:  J Am Vet Med Assoc       Date:  1997-11-01       Impact factor: 1.936

9.  Intraoperative detection and removal of microscopic residual sarcoma using wide-field imaging.

Authors:  Jeffrey K Mito; Jorge M Ferrer; Brian E Brigman; Chang-Lung Lee; Rebecca D Dodd; William C Eward; Lisa F Marshall; Kyle C Cuneo; Jessica E Carter; Shalini Ramasunder; Yongbaek Kim; W David Lee; Linda G Griffith; Moungi G Bawendi; David G Kirsch
Journal:  Cancer       Date:  2012-03-21       Impact factor: 6.860

10.  A Fluorescence-Guided Laser Ablation System for Removal of Residual Cancer in a Mouse Model of Soft Tissue Sarcoma.

Authors:  Alexander L Lazarides; Melodi J Whitley; David B Strasfeld; Diana M Cardona; Jorge M Ferrer; Jenna L Mueller; Henry L Fu; Suzanne Bartholf DeWitt; Brian E Brigman; Nimmi Ramanujam; David G Kirsch; William C Eward
Journal:  Theranostics       Date:  2016-01-01       Impact factor: 11.556

View more
  4 in total

1.  Intra-operative imaging of surgical margins of canine soft tissue sarcoma using optical coherence tomography.

Authors:  Laura E Selmic; Jonathan Samuelson; Jennifer K Reagan; Kelly J Mesa; Elizabeth Driskell; Joanne Li; Marina Marjanovic; Stephen A Boppart
Journal:  Vet Comp Oncol       Date:  2018-11-13       Impact factor: 2.613

Review 2.  Progresses in Fluorescence Imaging Guidance for Bone and Soft Tissue Sarcoma Surgery.

Authors:  Zhenyi Chen; Huayi Huang; Siyuan He; Yi Wang; Lin Cai; Yuanlong Xie
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

3.  A Tumor-Activatable Theranostic Nanomedicine Platform for NIR Fluorescence-Guided Surgery and Combinatorial Phototherapy.

Authors:  Xiaoning Li; Canan Schumann; Hassan A Albarqi; Christopher J Lee; Adam W G Alani; Shay Bracha; Milan Milovancev; Olena Taratula; Oleh Taratula
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

4.  CSCs: regenerating optimism for osteosarcoma treatment.

Authors:  Adam S Levin
Journal:  Oncotarget       Date:  2018-08-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.